Trump Appeals To Modi To Lift Hold On Export Of Anti-Malaria Drug For COVID

WASHINGTON: President of the United States, Donald Trump has said that he requested Narendra Modi, the prime minister of India to pass the orders which have been placed by America with India based pharmaceutical companies for hydroxychloroquine doses. This drug is used to prevent and treat malaria and has proved to be somewhat effective in treating COVID-19 cases. Trump feels this medication is revolutionary in this worldwide battle against coronavirus. 

At one of the daily White House briefing sessions on coronavirus, Trump revealed that he made a call to Modi and requested him to “release the amounts we ordered.” He also didn't fail to mention, "They are giving it serious consideration.” Modi took to his official Twitter handle to confirm that he indeed get a phone call from the US president but did not mention any special request made by him.

Also Read: COVID-19: US Records Highest Deaths In 24 Hours; Guidelines To Wear Mask

It was revealed through a readout by White house that in the telephonic conversation between the two, it was discussed how the two nations can join forces to fight off the rapidly increasing coronavirus pandemic. They also, "agreed to remain in touch on the issue of global supply chains for critical pharmaceuticals and medical supplies and to ensure they continue to function as smoothly as possible during the global health crisis."

Also Read: COVID-19: US Records Nearly 1,500 Death; 1,099,389 Cases Worldwide

India is known to be one of the major manufacturers of hydroxychloroquine. The drug is used for the treatment of malaria and lupus. India banned its export in terms of an active pharmaceutical ingredient and its formulations from 25 March 2020. However, India is using the drug as a prophylactic for healthcare workers who are exposed to and are dealing with COVID-19 positive patients.